C4 Therapeutics Cash Flow Statement (2019-2026) | CCCC

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Operating Activities
Net Income (Quarter)	-22.58M	-24.68M	-15.66M	-31.62M	-26.88M	-31.96M	-37.19M	-34.78M	-35.92M	-27.04M	-34.76M	-28.36M	-17.72M	-24.67M	-34.57M	-26.32M	-26.02M	-32.17M	-20.36M	-25.13M
Depreciation and Depletion (Quarter)	0.39M	0.33M	0.32M	0.30M	0.43M	0.41M	0.52M	0.50M	0.46M	0.45M	0.13M	0.38M	0.30M	0.36M	0.36M	0.36M	0.42M	0.38M	0.38M	0.36M
Share-based Compensation (Quarter)	5.23M	6.09M	6.35M	8.94M	8.15M	6.01M	6.92M	6.25M	6.42M	8.20M	6.36M	6.21M	6.38M	8.83M	8.23M	5.51M	4.99M	4.59M	4.01M	2.67M
Gains from Investment Securities (Quarter)	1.40M	1.63M	20.13M	44.07M
Asset Writedowns and Impairment (Quarter)																		10.73M
Non-cash Items (Quarter)	0.97M	1.12M	1.36M	1.67M
Cash from Operations (Quarter)	-18.00M	-18.36M	-25.67M	-26.60M	-22.20M	-28.02M	-29.13M	-33.12M	-19.00M	-30.71M	-24.01M	-18.12M	-4.97M	-24.13M	-17.93M	-33.28M	-12.06M	-31.21M	-22.14M	-29.94M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)	0.04M	-1.39M	1.75M	1.18M	-0.83M	4.04M	-3.68M	0.18M	2.87M	1.55M	1.56M	1.58M	1.35M	1.39M	2.11M	0.78M	0.58M	3.64M	1.43M	1.09M
Depreciation & Amortization (CF) (Quarter)	0.39M	0.33M	0.32M	0.30M	0.43M	0.41M	0.52M	0.50M	0.46M	0.45M	0.43M	0.45M	0.45M	0.44M	0.48M	0.46M	0.61M	0.46M	0.43M	0.40M
Change in Working Capital
Change in Receivables (Quarter)	2.56M	-1.37M	0.87M	-3.94M	-0.06M	-0.22M	-0.01M	-0.94M	0.50M	-0.53M	11.30M	1.80M	-12.43M	9.17M	-7.24M	4.93M	-5.83M	4.34M	-4.14M	0.48M
Change in Account Payables (Quarter)	0.63M	-0.60M	0.76M	-1.15M	0.59M	-1.69M	-1.08M	-0.14M	1.08M	-0.84M	0.17M	0.18M	-0.71M	0.59M	-0.18M	-0.65M	1.53M	-0.89M	-0.47M	-0.09M
Change in Accured Expenses (Quarter)	3.98M	1.93M	2.13M	-3.77M	3.68M	2.48M	2.69M	-3.67M	0.54M	-0.73M	5.18M	-7.66M	-1.75M	4.17M	3.98M	-6.73M	0.63M	-2.02M	2.07M	-3.52M
Other Working Capital Changes (Quarter)	1.14M	-0.06M	-2.01M	-5.88M	4.90M	-20.29M	20.89M	-2.73M	7.84M	-10.57M	2.74M	18.56M	-21.12M	6.86M	0.03M	0.03M	-2.86M	-7.32M	-8.68M	-0.12M
Investing Activities
Capital Expenditures (Quarter)	0.75M		0.11M	0.17M	3.10M	-1.81M	-0.98M	0.20M	0.03M	1.33M	-1.53M		0.01M	0.17M	-0.00M		0.29M	0.30M	0.01M	0.04M
Change in Acquisitions & Divestments (Quarter)	94.50M	54.08M	86.11M	72.39M	65.67M	78.33M	67.06M	65.56M	64.15M	90.27M	69.98M	54.35M	55.72M	68.71M	54.45M	54.77M	60.79M	51.18M	52.35M	57.03M
Cash from Investing Activities (Quarter)	32.43M	-100.63M	-59.41M	-4.00M	33.23M	19.91M	9.28M	53.53M	15.15M	57.73M	31.95M	-53.40M	-11.71M	0.16M	13.67M	29.12M	38.92M	4.09M	-80.73M	16.15M
Financing Activities
Other financing activities (Quarter)	11.30M	0.18M	-0.29M	0.22M		0.15M		0.10M	0.00M	0.26M	-0.00M	0.08M		0.30M	0.00M	0.11M		0.16M	0.00M	0.06M
Cash from Financing Activities (Quarter)	170.50M	0.58M	0.47M	0.48M	0.26M	0.36M	0.05M	-0.68M	-0.75M	-10.75M	57.67M	34.58M	0.14M	10.51M	0.11M	-0.05M		7.77M	118.67M	0.46M
Additional items
Change in Cash (Quarter)	184.93M	-118.40M	-84.62M	-30.12M	11.29M	-7.75M	-19.80M	19.72M	-4.59M	16.27M	65.61M	-36.93M	-16.55M	-13.46M	-4.15M	-4.21M	26.86M	-19.35M	15.79M	-13.33M
Beginning Cash Balance (Quarter)								0.75M	0.75M	11.00M
Free Cash Flow (Quarter)	-18.75M	-18.36M	-25.78M	-26.77M	-25.29M	-26.20M	-28.15M	-33.32M	-19.02M	-32.03M	-22.48M	-18.12M	-4.99M	-24.30M	-17.93M	-33.28M	-12.35M	-31.51M	-22.16M	-29.98M
Net Cash Flow (Quarter)	184.93M	-118.40M	-84.62M	-30.12M	11.29M	-7.75M	-19.80M	19.72M	-4.59M	16.27M	65.61M	-36.93M	-16.55M	-13.46M	-4.15M	-4.21M	26.86M	-19.35M	15.79M	-13.33M

Research Tools

C4 Therapeutics Cash Flow Statement (2019-2026) | CCCC

Create an account

Sign In

Reset Password